These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6412341)

  • 21. [Multiple sclerosis].
    Nyland H; Myhr KM
    Tidsskr Nor Laegeforen; 1995 Jun; 115(17):2072-7. PubMed ID: 7544032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Modern therapeutic viewpoints in the treatment of multiple sclerosis].
    Neumayer E
    Wien Med Wochenschr; 1969 Apr; 119(15):281-4. PubMed ID: 5769603
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New knowledge on the treatment of multiple sclerosis patients].
    Neu I
    Fortschr Med; 1982 Dec; 100(45):2110. PubMed ID: 7173796
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple sclerosis: clinical presentation, diagnosis and treatment.
    Brod SA; Lindsey JW; Wolinsky JS
    Am Fam Physician; 1996 Sep; 54(4):1301-6, 1309-11. PubMed ID: 8816574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Review of the therapy of multiple sclerosis].
    De Rosa A; Puccini A; De Martino V
    Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
    [No Abstract]   [Full Text] [Related]  

  • 27. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic trials for multiple sclerosis.
    McKhann GM
    Ann Neurol; 1990 Jun; 27(6):589-90. PubMed ID: 2193612
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppressive treatment in multiple sclerosis].
    Minderhoud JM; Prange AJ; Luijckx GJ
    Ned Tijdschr Geneeskd; 1987 May; 131(22):966-7. PubMed ID: 3299110
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current methods of the multiple sclerosis treatment].
    Kovalenko PA; Shamanskiĭ SV; Baziĭ NI
    Voen Med Zh; 2001 Oct; 322(10):45-52. PubMed ID: 11764483
    [No Abstract]   [Full Text] [Related]  

  • 31. [Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
    Meyer-Rienecker H; Hitzschke B
    Nervenarzt; 1974 Mar; 45(3):133-41. PubMed ID: 4598802
    [No Abstract]   [Full Text] [Related]  

  • 32. Link of the mechanisms of action of glatiramer acetate to its long-term clinical data.
    Moreau T
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S12-5. PubMed ID: 19200858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U; Majeron M; Mascetti A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple sclerosis.
    Ford H; Nicholas R
    Clin Evid; 2005 Dec; (14):1637-51. PubMed ID: 16620466
    [No Abstract]   [Full Text] [Related]  

  • 35. Relapse in multiple sclerosis.
    Galea I; Ward-Abel N; Heesen C
    BMJ; 2015 Apr; 350():h1765. PubMed ID: 25872511
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment and prevention of myelin disorders: multiple sclerosis.
    Abramsky O
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915
    [No Abstract]   [Full Text] [Related]  

  • 37. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
    Frohman EM; Havrdova E; Lublin F; Barkhof F; Achiron A; Sharief MK; Stuve O; Racke MK; Steinman L; Weiner H; Olek M; Zivadinov R; Corboy J; Raine C; Cutter G; Richert J; Filippi M
    Arch Neurol; 2006 Apr; 63(4):614-9. PubMed ID: 16606781
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular immunity in multiple sclerosis. Implications for pathogenesis and treatment.
    Thompson RF; Davenport J
    Mo Med; 1984 Oct; 81(10):669-73. PubMed ID: 6092887
    [No Abstract]   [Full Text] [Related]  

  • 39. [Update: treatment of multiple sclerosis].
    Kümpfel T; Hohlfeld R
    MMW Fortschr Med; 2009 Mar; 151(13):70-2. PubMed ID: 19504824
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic indications for acute episodes of multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):988-95. PubMed ID: 11787365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.